首先在欧洲的英国医院,用非侵入性超声波治疗肝癌,使同一天的出院成为可能。 UK hospital first in Europe to treat liver cancer with non-invasive ultrasound, enabling same-day discharge.

爱登布鲁克(Adenbrooke)位于剑桥(Cambridge)的医院已成为欧洲第一个利用临床试验以外的非侵入性超声波程序 -- -- 直肠检查治疗肝癌患者的医院。 Addenbrooke’s Hospital in Cambridge has become the first in Europe to treat a liver cancer patient using histotripsy, a non-invasive ultrasound procedure, outside of clinical trials. 通过英国未满足临床需要授权批准的治疗,在没有手术、辐射或化疗的情况下使用有重点的声波摧毁了肿瘤,使病人Roger Jackson(80岁)可以在第二天出院。 The treatment, approved via the UK’s Unmet Clinical Need Authorisation, destroyed tumors using focused sound waves without surgery, radiation, or chemotherapy, allowing patient Roger Jackson, 80, to be discharged the next day. 这项技术是美国和林业发展局于2023年批准的,现已在全球2 000多名患者中应用。 The technology, developed in the U.S. and FDA-approved in 2023, has been used in over 2,000 patients globally. NHS领导人和卫生部长Wes Streeting称此举是一大进步,有望更快恢复,缩短住院时间,改善获得创新癌症护理的机会。 NHS leaders and Health Secretary Wes Streeting hailed the move as a major advance, promising faster recovery, shorter hospital stays, and improved access to innovative cancer care.